Stéphane Vinzio

Suggest Changes
Learn More
OBJECTIVE To evaluate at 9 months and 24 months the safety and efficacy of intravenous immunoglobulins (IVIGs) administered for 6 months to treat relapses of Wegener's granulomatosis (WG) or(More)